Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04393454
Title Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Albert Einstein College of Medicine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST